We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Judge Sides With Par in Novartis’ Patent Lawsuit Over Exelon
Judge Sides With Par in Novartis’ Patent Lawsuit Over Exelon
A federal judge has ruled that Par Pharmaceutical’s generic version of the Novartis Alzheimer’s treatment Exelon Patch did not infringe on the brand manufacturer’s patent.